Burden, Outcome, and Comorbidities of Extrahepatic Manifestations in Hepatitis C Virus Infection

Busara Songtanin1, Kenneth Nugent1

  • 1Department of Internal Medicine, Texas Tech University Health Sciences Center, Lubbock, TX 79430, USA.

Biology
|January 21, 2023
PubMed

Insights

Hepatitis C virus (HCV) causes liver disease and serious non-liver complications. New treatments offer a cure, but understanding and managing these extrahepatic manifestations remains crucial.

Area of Science:

  • Hepatology
  • Virology
  • Immunology

Background:

  • Hepatitis C virus (HCV) infection leads to chronic liver disease, cirrhosis, and hepatocellular carcinoma.
  • HCV is linked to significant extrahepatic manifestations (EHMs) like cryoglobulinemia, diabetes, and lymphoma.
  • These EHMs increase disease complexity, mortality, and healthcare costs globally.

Purpose of the Study:

  • To provide an updated review of HCV-associated extrahepatic manifestations.
  • To highlight the prevalence, risk factors, and disease burden of HCV EHMs.
  • To discuss current treatment strategies for managing HCV EHMs.

Main Methods:

  • Literature review of studies on Hepatitis C virus and its extrahepatic manifestations.
  • Analysis of prevalence, risk factors, and clinical impact of HCV-associated EHMs.
  • Synthesis of information on treatment outcomes and management of these conditions.

Main Results:

  • Direct-acting antiviral agents (DAAs) achieve high cure rates and reduce EHM burden.
  • Despite effective treatment, HCV EHMs remain a significant clinical concern.
  • Understanding viral mechanisms driving EHMs is essential for comprehensive patient care.

Conclusions:

  • HCV treatment with DAAs has improved outcomes by reducing EHM incidence and severity.
  • Continued research is needed to fully elucidate the pathogenesis of HCV EHMs.
  • Managing EHMs is vital for improving the quality of life and survival of HCV patients.

Related Concept Videos

Diseases of the Liver and Gallbladder01:26

Diseases of the Liver and Gallbladder

Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
869
Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.01:25

Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.

Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
2.9K
Pleural Effusion II: Symptoms and Management01:28

Pleural Effusion II: Symptoms and Management

Pleural Effusion Overview
A pleural effusion is the abnormal collection of fluid between the parietal and visceral pleura layers of tissue that form the lining of the lungs and chest cavity. It can occur independently or due to surrounding parenchymal diseases, such as infection, malignancy, or inflammatory conditions.
Clinical Manifestations:
241
Esophageal Varices-II: Clinical Features and Management01:28

Esophageal Varices-II: Clinical Features and Management

Esophageal varices often manifest as gastrointestinal bleeding episodes, presenting symptoms like hematemesis (vomiting of blood), hematochezia (passing fresh blood via the rectum), and melena (black, tarry stools). Other signs can include weight loss, anorexia, abdominal discomfort, jaundice, pruritus, altered mental status, and muscle cramps.
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
113
Hepatic Drug Excretion: Influencing Factors01:16

Hepatic Drug Excretion: Influencing Factors

The biliary system of the liver, crucial for bile secretion and drug excretion, comprises intrahepatic bile ducts that merge to form the common hepatic duct. This duct, carrying hepatic bile, combines with the cystic duct, draining the gallbladder and forming the common bile duct, which empties into the duodenum. Bile, produced by hepatic cells lining the bile canaliculi, is composed primarily of water, bile salts, pigments, electrolytes, and lesser amounts of cholesterol and fatty acids. Bile...
181
Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
59